Integrative Modeling of Multiomics Data for Predicting Tumor Mutation Burden in Patients with Lung Cancer

Immunotherapy has been widely used in the treatment of lung cancer, and one of the most effective biomarkers for the prognosis of immunotherapy currently is tumor mutation burden (TMB). Although whole-exome sequencing (WES) could be utilized to assess TMB, several problems prevent its routine clinic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jun, Chen, Peng, Su, Mingyang, Zhong, Guocheng, Zhang, Shasha, Gou, Deming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794677/
https://www.ncbi.nlm.nih.gov/pubmed/35097114
http://dx.doi.org/10.1155/2022/2698190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794677/
https://www.ncbi.nlm.nih.gov/pubmed/35097114
http://dx.doi.org/10.1155/2022/2698190

Ejemplares similares